Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

PROSPECTIVE INVESTIGATION FOR PULMONARY EMBOLISM DX III

Award Number: U01HL081594
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/05/2005
PERIOD OF PERFORMANCE END DATE: 05/31/2010

Group Awards By:

View Award Description

PROSPECTIVE INVESTIGATION FOR PULMONARY EMBOLISM DX III - DESCRIPTION (provided by applicant): The Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III) is a rnulticenter prospective | investigation designed to determine the diagnostic accuracy of gadolinium enhanced magnetic resonance angiography of the pulmonary arteries (Gd-MRA) in combination with magnetic resonance venography of the veins of the thighs (MRV) in patients with clinically suspected acute pulmonary embolism (PE). This is the proposal for the St.Joseph Mercy Oakland Clincial Center. The diagnostic accuracy of Gd-MRA alone and in combination with MRV will be expressed as sensitivity, specificity, and likelihood ratio for positive and negative tests. The study design is a prospective study of consecutive patients incorporating standardized inclusion/exclusion criteria, complete ascertainment of patient characteristics and outcomes, uniform diagnostic criteria, and unbiased paired central readings of imaging studies. Over a period of two years, 1256 patients with suspected acute PE will be recruited at 7 clinical centers. Composite reference standards will be used to diagnose VTE and exclude PE. It is expected that 314 patients will have acute VTE and they will undergo Gd-MRA/MRV. It is expected that 942 patients will be shown not to have PE. From among this group, 314 patients will be randomly selected for the index test, Gd-MRA/MRV. The strengths of this proposal are: 1) the importance of the problem ofPE in terms of lives lost from undem'iagnosis and major bleeding from overdiagnosis, 2) the potential aplicability of a new technology for the diagnosis of PE-, 3) a strong investigative team that has collaborated previously in successful reaearch in PE, 4) a protocol that parallels previously proven protocols for the evaluation of a diagnostic test for PE. The St. Joseph Mercy Oakland Clinical Center adds to the strength of PIOPED III by showing that Gd-MRA/MRV can be used successfully for the diiagnosis of VTE in a nonuniversity hospital.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2010 ( Subtotal = -$172,520 )
2010	2008	TRINITY HEALTH-ST JOSEPH MERCY-OAKLAND	44405 WOODWARD AVENUE	PONTIAC	MI	48341	OAKLAND	USA	Lung Diseases Research	000	4	5/24/2010	NON-COMPETING CONTINUATION	-$172,520
														Subtotal = -$172,520

Issue Date FY: 2008 ( Subtotal = $218,020 )
2008	2008	TRINITY HEALTH-ST JOSEPH MERCY-OAKLAND	44405 WOODWARD AVENUE	PONTIAC	MI	48341	OAKLAND	USA	Lung Diseases Research	000	4	6/24/2008	NON-COMPETING CONTINUATION	$218,020
														Subtotal = $218,020

Issue Date FY: 2007 ( Subtotal = $139,250 )
2007	2007	TRINITY HEALTH-ST JOSEPH MERCY-OAKLAND	44405 WOODWARD AVENUE	PONTIAC	MI	48341	OAKLAND	USA	Lung Diseases Research	000	3	9/24/2007	NON-COMPETING CONTINUATION	$139,250
														Subtotal = $139,250

Issue Date FY: 2006 ( Subtotal = $337,449 )
2006	2006	TRINITY HEALTH-ST JOSEPH MERCY-OAKLAND	44405 WOODWARD AVENUE	PONTIAC	MI	48341	OAKLAND	USA	Lung Diseases Research	000	2	5/30/2006	NON-COMPETING CONTINUATION	$337,449
														Subtotal = $337,449

Grand Total All Awards = $522,199

Top

All Categories

About

Search

Reports

Data Submission

Award Information

PROSPECTIVE INVESTIGATION FOR PULMONARY EMBOLISM DX III

Award Number: U01HL081594

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/05/2005

PERIOD OF PERFORMANCE END DATE: 05/31/2010

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer